On-treatment risk model for predicting treatment response in advanced renal cell carcinoma.

Guer, Melis; Janitzky, Andreas; Schostak, Martin

Guer, Melis; Janitzky, Andreas; Schostak, Martin.

Affiliation

Guer M; Clinic of Urology, Uro-Oncology, Robot-Assisted and Focal Therapy, University Hospital Magdeburg, Magdeburg, Germany. melis.guer@med.ovgu.de.
Janitzky A; Clinic of Urology, Uro-Oncology, Robot-Assisted and Focal Therapy, University Hospital Magdeburg, Magdeburg, Germany.
Schostak M; Clinic of Urology, Uro-Oncology, Robot-Assisted and Focal Therapy, University Hospital Magdeburg, Magdeburg, Germany.

World J Urol ; 41(10): 2735-2742, 2023 Oct.

Article in En | MEDLINE | ID: mdl-37552264

Subject(s)

Carcinoma, Renal Cell; Kidney Neoplasms; Humans; Carcinoma, Renal Cell/drug therapy; Kidney Neoplasms/drug therapy; Retrospective Studies; C-Reactive Protein/metabolism; Disease Progression

Key words

Advanced renal cell carcinoma; C-Reactive protein; Checkpoint inhibitors; Predictive biomarker; Treatment-related adverse events

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: World J Urol Year: 2023 Type: Article Affiliation country: Germany

Fulltext

XML

PubMed Links

Search on Google